News Related to Bleeding Disorders

Related coverage linked through entity extraction aliases.

Orphan Drug Designation Drives Rare Disease Therapy Development Across Global Markets

Mar 15, 2026

Regulatory incentives for rare disease treatments, including market exclusivity and development subsidies, are spurring pharmaceutical innovation across the US, Europe, Japan, and Australia, with multiple companies advancing therapies for conditions affecting limited patient populations.

Aspirin Shows No Quick Benefit for General Population but Reduces Cancer Risk in IBD Patients

Feb 26, 2026

Daily aspirin use does not prevent bowel cancer in the general population within 5-15 years and carries immediate bleeding risks, according to a new Cochrane review. However, long-term low-dose aspirin is associated with lower colorectal cancer risk in IBD patients.